Cover Image
市場調查報告書

放射性醫藥品:技術及全球市場

Radiopharmaceuticals: Technologies and Global Markets

出版商 BCC Research 商品編碼 311757
出版日期 內容資訊 英文 126 Pages
訂單完成後即時交付
價格
Back to Top
放射性醫藥品:技術及全球市場 Radiopharmaceuticals: Technologies and Global Markets
出版日期: 2014年09月04日 內容資訊: 英文 126 Pages
簡介

全球放射性醫藥品市場2012年為38億美元,2013年達39億美元規模。預計該市場2014年擴大到44億美元,今後到2019年以年複合成長率8%擴大,達約64億美元。

本報告提供全球放射性醫藥品及相關技術市場概要、2014年、2019年的市場趨勢預測、放射性醫藥品對各種疾病的使用方法、法律制度,及打入市場的主要企業簡介等彙整資料。

第1章 簡介

第2章 摘要整理

第3章 概要

  • 用語
  • 歷史背景
  • 放射性核種的起源
  • 崩壞形式
  • 用醫療一般地所採用的放射性核種
  • 放射性醫藥品的用途
  • 放射性醫藥品的優點與缺點

第4章 相關法規方面

  • 新藥認證與申請
  • 新藥申請
  • 安全性警報
  • 不利事件報告
  • 藥物不足
  • 放射性核種的近距離放射治療的510k認證

第5章 新的開發趨勢

  • 開發中產品
  • 在放射性醫藥品中其他重要的新開發

第6章 放射性醫藥品的市場分析

  • 各類型市場
  • 各類型市場佔有率
  • 各類型治療用放射性醫藥品
  • 各類型治療方法放射性醫藥品市場佔有率
  • 診斷用放射性醫藥品的各地區市場
  • 治療用放射性醫藥品的各地區市場
  • 各生產方法放射性醫藥品市場

第7章 生物醫藥品的產業結構

  • 診斷用放射性醫藥品
    • PET診斷
    • SPECT診斷
    • 其他
  • 治療用放射性醫藥品
    • 市場領導
    • 市場佔有率

第8章 專利分析

第9章 現狀

  • 法律規章的問題
  • 戰後嬰兒潮世代
  • 關乎生死的疾病發病率上升
  • 意識提升
  • 競爭
  • 技術的進步
  • 產業的後退
  • 合併、收購、聯合
  • 研究資金籌措

第10章 企業簡介

第11章 簡稱說明

圖表

目錄
Product Code: PHM171A

REPORT HIGHLIGHTS

The global market for radiopharmaceuticals in 2012 was about $3.8 billion and $3.9 billion in 2013. The estimated market for the year 2014 is nearly $4.4 billion and this figure is forecast to expand through 2019 at a projected compound annual growth rate (CAGR) of 8%, approaching $6.4 billion.

This report provides:

  • An overview of the global market for radiopharmaceuticals and related technologies.
  • Analyses of global market trends, with data from 2012 and 2013, estimates for 2014, and projections of CAGRs through 2019.
  • Information on how radiopharmaceuticals are used to diagnose cancer, tumors, brain diseases, bone diseases, bone marrow diseases, colorectal disease, kidney diseases, liver diseases, lung diseases, and many others.
  • Details concerning the regulatory environment and the impacts of government on the market.
  • Profiles of leading companies in the industry.

SCOPE OF THE STUDY

The scope of this study encompasses radiopharmaceuticals in pharmaceutical markets. BCC Research analyzes each market and its applications, regulatory environment, technology, market projections and market shares. The report also covers the brachytherapy seeds. Technological issues include the latest trends and developments. The emerging market for radiopharmaceuticals includes countries like India, China, Japan, Korea, Taiwan, Canada, Africa, Australia and New Zealand.

ANALYSTS' CREDENTIALS

The study has been carried out by a team of professionals in biotechnology industry. The project manager for this project is Shalini S. Dewan, who holds a master's degree in pharmaceutical chemistry and has more than 15 years of industry experience. Shalini was awarded a Gold Medal by the Prime Minister of India for her work and has worked with top companies in India and in the U.S.

Table of Contents

CHAPTER 1 - INTRODUCTION

  • STUDY OBJECTIVES
  • REASONS FOR DOING THIS STUDY
  • CONTRIBUTIONS OF THE STUDY AND INTENDED AUDIENCE
  • SCOPE OF THE STUDY
  • METHODOLOGY
  • INFORMATION SOURCES
  • ANALYSTS' CREDENTIALS
  • RELATED BCC RESEARCH REPORTS
  • BCC RESEARCH WEBSITE
  • DISCLAIMER

CHAPTER 2 - SUMMARY

  • SUMMARY TABLE: GLOBAL REVENUE OF RADIOPHARMACEUTICALS BY REGION, THROUGH 2019 ($ MILLIONS)
  • SUMMARY FIGURE: GLOBAL REVENUE OF RADIOPHARMACEUTICALS BY REGION, 2012-2019 ($ MILLIONS)

CHAPTER 3 - OVERVIEW

  • TERMINOLOGY
    • RADIOPHARMACEUTICAL
    • RADIONUCLIDE
    • RADIOACTIVITY
    • RADIOACTIVE DECAY
    • NEGATRON
    • POSITRON
    • ELECTRON CAPTURE
    • ISOMERIC TRANSITION
    • TRANSMUTATION
    • HALF-LIFE
    • RADIATION
    • NUCLEAR MEDICINE
    • MYELOSUPPRESSION
    • LINEAR ENERGY TRANSFER (LET)
    • FISSION
  • HISTORICAL BACKGROUND
    • TABLE 1: DISCOVERY OF RADIOACTIVITY AND NUCLEAR MEDICINE
  • ORIGIN OF RADIONUCLIDES
    • PARTICLE ACCELERATOR-PRODUCED RADIONUCLIDES
      • TABLE 2: CYCLOTRON RADIONUCLIDE/RADIOISOTOPES
    • NUCLEAR REACTOR-PRODUCED RADIONUCLIDES
      • TABLE 3: NUCLEAR REACTOR RADIONUCLIDES/RADIOISOTOPES
    • RADIONUCLIDE GENERATORS
      • TABLE 4: RADIONUCLIDE GENERATORS
  • MODES OF DECAY
  • COMMONLY USED RADIONUCLIDES IN MEDICINE
    • TECHNETIUM-99M
    • IODINE-123
    • THALLIUM-201
    • GALLIUM-67
  • APPLICATIONS OF RADIOPHARMACEUTICALS
    • DIAGNOSTIC USE OF RADIOPHARMACEUTICALS
      • TABLE 5: EXAMPLES OF DIAGNOSTIC RADIOPHARMACEUTICALS
    • TYPES OF DIAGNOSTIC RADIOPHARMACEUTICALS
      • PET Radiopharmaceuticals
      • SPECT Radiopharmaceuticals
    • THERAPEUTIC RADIOPHARMACEUTICALS
      • TABLE 6: EXAMPLES OF THERAPEUTIC RADIOPHARMACEUTICALS
      • Alpha Emitters
        • TABLE 7: EXAMPLES OF ALPHA EMITTERS
        • TABLE 8: ADVANTAGES AND DISADVANTAGES OF ALPHA EMITTERS
      • Beta Emitters
        • TABLE 9: ADVANTAGES AND DISADVANTAGES OF BETA EMITTERS
      • Brachytherapy
        • TABLE 10: COMMONLY USED RADIONUCLIDES (RADIATION SOURCES) FOR BRACHYTHERAPY
      • TABLE 11: ADVANTAGES AND DISADVANTAGES OF BRACHYTHERAPY
  • ADVANTAGES AND DISADVANTAGES OF RADIOPHARMACEUTICALS
    • TABLE 12: ADVANTAGES AND DISADVANTAGES OF RADIOPHARMACEUTICALS

CHAPTER 4 - REGULATORY ASPECTS

  • NEW DRUG APPROVALS AND APPLICATIONS
    • TABLE 13: NEW DRUG APPROVALS (FROM 2011- MARCH 2014)
  • NEW DRUG APPLICATIONS
    • TABLE 14: NEW DRUG APPLICATIONS (FROM 2010-MARCH 2014)
  • SAFETY ALERTS
    • TABLE 15: SAFETY ALERTS FOR RADIOPHARMACEUTICALS (FROM 2010-MARCH 2014)
  • ADVERSE EVENT REPORTING
    • TABLE 16: ADVERSE EVENT REPORTING (FROM 2010-MARCH 2014)
  • DRUG SHORTAGE
    • TABLE 17: RESOLVED DRUG SHORTAGE IN 2013
  • 510K APPROVALS FOR RADIONUCLIDE BRACHYTHERAPY SOURCE
    • TABLE 18: 510K APPROVALS (FROM 2010-MARCH 2014)

CHAPTER 5 - NEW DEVELOPMENTS

  • PIPELINE PRODUCTS
    • TABLE 19: PIPELINE PRODUCTS IN RADIOPHARMACEUTICALS
  • OTHER SIGNIFICANT NEW DEVELOPMENTS IN RADIOPHARMACEUTICALS

CHAPTER 6 - MARKET ANALYSIS OF RADIOPHARMACEUTICALS

  • MARKET BY TYPES OF RADIOPHARMACEUTICALS
    • GLOBAL RADIOPHARMACEUTICALS MARKET
      • TABLE 20: MARKET FOR RADIOPHARMACEUTICALS BY CATEGORY, THROUGH 2019 ($ MILLIONS)
      • FIGURE 1: MARKET FOR RADIOPHARMACEUTICALS BY CATEGORY, 2012-2019 ($ MILLIONS)
      • Market Share
        • TABLE 21: MARKET SHARE OF RADIOPHARMACEUTICALS BY CATEGORY IN 2013 (%)
        • FIGURE 2: MARKET SHARE OF RADIOPHARMACEUTICALS BY CATEGORY IN 2013 (%)
    • DIAGNOSTIC RADIOPHARMACEUTICALS MARKET BY TYPE OF DIAGNOSTIC TEST
      • Market Overview
      • Market Revenue
        • TABLE 22: MARKET FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE OF DIAGNOSTIC TEST, THROUGH 2019 ($ MILLIONS)
        • FIGURE 3: MARKET FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE OF DIAGNOSTIC TEST, 2012-2019 ($ MILLIONS)
      • PET Radiopharmaceuticals
        • PET Radiopharmaceuticals Market by Region
          • Market Overview
          • Market Revenue
            • TABLE 23: MARKET FOR PET RADIOPHARMACEUTICALS BY REGION, THROUGH 2019 ($ MILLIONS)
            • FIGURE 4: MARKET FOR PET RADIOPHARMACEUTICALS BY REGION, THROUGH 2019 ($ MILLIONS)
        • PET Radiopharmaceuticals Market by Type of Radionuclide
          • Market Overview
          • Market Revenue
            • TABLE 24: MARKET FOR PET RADIOPHARMACEUTICALS BY TYPE OF RADIONUCLIDE, THROUGH 2019 ($ MILLIONS)
            • FIGURE 5: MARKET FOR PET RADIOPHARMACEUTICALS BY TYPE OF RADIONUCLIDE, 2012-2019 ($ MILLIONS)
      • SPECT Radiopharmaceuticals
        • SPECT Radiopharmaceuticals Market by Region
          • Market Overview
          • Market Revenue
            • TABLE 25: MARKET FOR SPECT RADIOPHARMACEUTICALS BY REGION, THROUGH 2019 ($ MILLIONS)
            • FIGURE 6: MARKET FOR SPECT RADIOPHARMACEUTICALS BY REGION, THROUGH 2019 ($ MILLIONS)
        • SPECT Radiopharmaceuticals Market by Type of Isotope
          • Market Overview
          • Market Revenue
            • TABLE 26: MARKET FOR SPECT RADIOPHARMACEUTICALS BY TYPE OF RADIONUCLIDE, THROUGH 2019 ($ MILLIONS)
            • FIGURE 7: MARKET FOR SPECT RADIOPHARMACEUTICALS BY TYPE OF RADIONUCLIDE, THROUGH 2019 ($ MILLIONS)
      • Other Diagnostic Radiopharmaceuticals
        • Other Diagnostic Radiopharmaceuticals Market by Region
          • Market Overview
          • Market Revenue
            • TABLE 27: MARKET FOR OTHER DIAGNOSTIC RADIOPHARMACEUTICALS BY REGION, THROUGH 2019 ($ MILLIONS)
            • FIGURE 8: MARKET FOR OTHER DIAGNOSTIC RADIOPHARMACEUTICALS BY REGION, THROUGH 2019 ($ MILLIONS)
        • Other Diagnostic Radiopharmaceuticals Market By Type of Radionuclide
          • Market Overview
          • Market Revenue
            • TABLE 28: MARKET FOR OTHERS DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE OF RADIONUCLIDE, THROUGH 2019 ($ MILLIONS)
            • FIGURE 9: MARKET FOR OTHERS DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE OF RADIONUCLIDE, THROUGH 2019 ($ MILLIONS)
  • MARKET SHARE OF DIAGNOSTICS RADIOPHARMACEUTICAL BY TYPE
    • TABLE 29: MARKET SHARE OF DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE OF DIAGNOSTIC TEST IN 2013 (%)
    • FIGURE 10: MARKET SHARE OF DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE OF DIAGNOSTIC TEST IN 2013 (%)
  • THERAPEUTIC RADIOPHARMACEUTICALS BY TYPE
    • Market Overview
    • Market Revenue
      • TABLE 30: MARKET FOR THERAPEUTIC RADIOPHARMACEUTICALS BY TYPE, THROUGH 2019 ($ MILLIONS)
      • FIGURE 11: MARKET FOR THERAPEUTIC RADIOPHARMACEUTICALS BY TYPE, THROUGH 2019 ($ MILLIONS)
    • Alpha Emitters
      • Alpha Emitters Market by Region
        • Market Overview
        • Market Revenue
          • TABLE 31: MARKET FOR ALPHA EMITTERS BY REGION, THROUGH 2019 ($ MILLIONS)
          • FIGURE 12: MARKET FOR ALPHA EMITTERS BY REGION, THROUGH 2019 ($ MILLIONS)
      • Alpha Emitters Market by Type of Radionuclide
        • Market Overview
        • Market Revenue
          • TABLE 32: GLOBAL MARKET FOR ALPHA EMITTERS BY TYPE OF RADIONUCLIDE, THROUGH 2019 ($ MILLIONS)
          • FIGURE 13: GLOBAL MARKET FOR ALPHA EMITTERS BY TYPE OF RADIONUCLIDE, THROUGH 2019 ($ MILLIONS)
    • Beta Emitters
      • Beta Emitters Market by Region
        • Market Overview
        • Market Revenue
          • TABLE 33: MARKET FOR BETA EMITTERS BY REGION, THROUGH 2019 ($ MILLIONS)
          • FIGURE 14: MARKET FOR BETA EMITTERS BY REGION, THROUGH 2019 ($ MILLIONS)
      • Beta Emitters by Type of Radionuclide
        • Market Overview
        • Market Revenue
          • TABLE 34: GLOBAL MARKET FOR BETA EMITTERS BY TYPE OF RADIONUCLIDE, THROUGH 2019 ($ MILLIONS)
          • FIGURE 15: GLOBAL MARKET FOR BETA EMITTERS BY TYPE OF RADIONUCLIDE, THROUGH 2019 ($ MILLIONS)
    • Brachytherapy Seeds
      • Brachytherapy Seeds Market by Region
        • Market Overview
        • Market Revenue
          • TABLE 35: MARKET FOR BRACHYTHERAPY SEEDS BY REGION, THROUGH 2019 ($ MILLIONS)
          • FIGURE 16: MARKET FOR BRACHYTHERAPY SEEDS BY REGION, THROUGH 2019 ($ MILLIONS)
      • Brachytherapy Seeds Market by Type of Radioisotope
        • Market Overview
        • Market Revenue
          • TABLE 36: MARKET FOR BRACHYTHERAPY BY TYPE OF RADIONUCLIDE, THROUGH 2019 ($ MILLIONS)
          • FIGURE 17: MARKET FOR BRACHYTHERAPY BY TYPE OF RADIONUCLIDE, THROUGH 2019 ($ MILLIONS)
  • MARKET SHARE OF THERAPEUTIC RADIOPHARMACEUTICAL BY TYPE
    • TABLE 37: MARKET SHARE OF THERAPEUTIC RADIOPHARMACEUTICALS BY TYPE IN 2013 (%)
    • FIGURE 18: MARKET SHARE OF THERAPEUTIC RADIOPHARMACEUTICALS BY TYPE IN 2013 (%)
  • MARKETS BY REGION FOR DIAGNOSTIC RADIOPHARMACEUTICALS
    • MARKET OVERVIEW
    • MARKET REVENUE
      • TABLE 38: MARKET FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY REGION, THROUGH 2019 ($ MILLIONS)
      • FIGURE 19: MARKET FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY REGION, THROUGH 2019 ($ MILLIONS)
    • MARKET SHARE
      • TABLE 39: MARKET SHARE OF DIAGNOSTIC RADIOPHARMACEUTICALS BY REGION IN 2013 (%)
      • FIGURE 20: MARKET SHARE OF DIAGNOSTIC RADIOPHARMACEUTICALS BY REGION IN 2013 (%)
  • MARKETS BY REGION FOR THERAPEUTIC RADIOPHARMACEUTICALS
    • MARKET OVERVIEW
    • MARKET REVENUE
      • TABLE 40: MARKET FOR THERAPEUTIC RADIOPHARMACEUTICALS BY REGION, THROUGH 2019 ($ MILLIONS)
      • FIGURE 21: MARKET FOR THERAPEUTIC RADIOPHARMACEUTICALS BY REGION, THROUGH 2019 ($ MILLIONS)
    • MARKET SHARE
      • TABLE 41: MARKET SHARE OF THERAPEUTIC RADIOPHARMACEUTICALS BY REGION IN 2013 (%)
      • FIGURE 22: MARKET SHARE OF THERAPEUTIC RADIOPHARMACEUTICALS BY REGION IN 2013 (%)
  • RADIOPHARMACEUTICALS MARKET BY PRODUCTION METHOD
    • PARTICLE ACCELERATORS (CYCLOTRONS)
    • NUCLEAR REACTORS
    • RADIONUCLIDE GENERATORS
      • MARKET OVERVIEW
      • MARKET REVENUE
        • TABLE 42: MARKET FOR RADIOPHARMACEUTICALS BY PRODUCTION METHOD, THROUGH 2019 ($ MILLIONS)
        • FIGURE 23: MARKET FOR RADIOPHARMACEUTICALS BY PRODUCTION METHOD, THROUGH 2019 ($ MILLIONS)
      • MARKET SHARE
        • TABLE 43: MARKET SHARE OF RADIOPHARMACEUTICALS BY PRODUCTION METHOD, 2013 (%)
        • FIGURE 24: MARKET SHARE OF RADIOPHARMACEUTICALS BY PRODUCTION METHOD, 2013 (%)

CHAPTER 7 - INDUSTRY STRUCTURE FOR BIOPHARMACEUTICALS

  • DIAGNOSTIC RADIOPHARMACEUTICALS
    • PET DIAGNOSTIC RADIOPHARMACEUTICALS
      • Market Leaders
        • TABLE 44: GLOBAL MANUFACTURERS/SUPPLIERS OF PET RADIOPHARMACEUTICALS, 2013
      • Market Share
        • TABLE 45: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF PET RADIOPHARMACEUTICALS, 2013 (%)
        • FIGURE 25: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF PET RADIOPHARMACEUTICALS, 2013 (%)
    • SPECT DIAGNOSTIC RADIOPHARMACEUTICALS
      • Market Leaders
        • TABLE 46: GLOBAL MANUFACTURERS/SUPPLIERS OF SPECT RADIOPHARMACEUTICALS, 2013
      • Market Share
        • TABLE 47: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF SPECT RADIOPHARMACEUTICALS, 2013 (%)
        • FIGURE 26: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF SPECT RADIOPHARMACEUTICALS, 2013 (%)
    • OTHER DIAGNOSTIC RADIOPHARMACEUTICALS
      • Market Leaders
        • TABLE 48: GLOBAL MANUFACTURERS/ SUPPLIERS OF OTHER DIAGNOSTIC RADIOPHARMACEUTICALS, 2013
      • Market Share
        • TABLE 49: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF OTHER DIAGNOSTIC RADIOPHARMACEUTICALS, 2013 (%)
        • FIGURE 27: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF OTHER DIAGNOSTIC RADIOPHARMACEUTICALS, 2013 (%)
  • THERAPEUTIC RADIOPHARMACEUTICALS
    • MARKET LEADERS
      • TABLE 50: GLOBAL MANUFACTURERS/SUPPLIERS OF THERAPEUTIC RADIOPHARMACEUTICALS, 2013
    • MARKET SHARE
      • TABLE 51: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF THERAPEUTIC RADIOPHARMACEUTICALS, 2013 (%)
      • FIGURE 28: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF THERAPEUTIC RADIOPHARMACEUTICALS, 2013 (%)

CHAPTER 8 - PATENT ANALYSIS

  • PATENTS BY YEAR
    • TABLE 52: NUMBER OF SIGNIFICANT PATENTS BY YEAR, JANUARY 2010-APRIL 2014
    • FIGURE 29: NUMBER OF SIGNIFICANT PATENTS BY YEAR, JANUARY 2010-APRIL 2014
  • PATENTS BY TYPE/CATEGORY
    • TABLE 53: PATENTS BY CATEGORY, JANUARY 2010-APRIL 2014
    • FIGURE 30: PATENTS BY CATEGORY, JANUARY 2010-APRIL 2014
  • PATENTS BY COMPANY
    • TABLE 54: NUMBER OF U.S. PATENTS BY COMPANY, JANUARY 2010-APRIL 2014
    • FIGURE 31: NUMBER OF U.S. PATENTS BY COMPANY, JANUARY 2010-APRIL 2014
  • PATENTS BY COUNTRY
    • TABLE 55: NUMBER OF U.S. PATENTS BY COUNTRY, JANUARY 2010-APRIL 2014
    • FIGURE 32: NUMBER OF U.S. PATENTS BY COUNTRY, JANUARY 2010-APRIL 2014
    • TABLE 56: PATENT SHARES, BY COUNTRY, JANUARY 2010-APRIL 2014 (%)
    • FIGURE 33: PATENT SHARES BY COUNTRY, JANUARY 2010-APRIL 2014 (%)
  • PATENTS BY ASSIGNEE
    • TABLE 57: NUMBER OF PATENTS BY ASSIGNEE, JANUARY 2010-APRIL 2014
    • FIGURE 34: NUMBER OF PATENTS BY ASSIGNEE, JANUARY 2010-APRIL 2014

CHAPTER 9 - CURRENT SITUATION

  • REGULATORY ISSUES
  • BABY-BOOMER GENERATION
  • INCREASING INCIDENCE OF LIFE THREATENING DISEASES
  • RISING AWARENESS
  • COMPETITION
  • TECHNOLOGICAL ADVANCEMENTS
  • SETBACKS IN INDUSTRY
  • MERGERS, ACQUISITIONS AND COLLABORATIONS
  • FUNDING FOR RESEARCH

CHAPTER 10 - COMPANY PROFILES

  • ACTINIUM PHARMACEUTICALS INC.
  • ADVANCED MEDICAL ISOTOPE CORP.
  • ALSERES PHARMACEUTICALS INC.
  • AUSTRALIAN NUCLEAR ASSOCIATION AND TECHNOLOGY ORGANIZATION (ANSTO)
  • AVID RADIOPHARMACEUTICALS INC.
  • BARD MEDICAL
  • BAYER HEALTHCARE PHARMACEUTICALS
  • BOARD OF RADIATION AND ISOTOPE TECHNOLOGY (BRIT)
  • BRACCO DIAGNOSTICS INC.
  • CARDINAL HEALTH INC.
  • ELI LILLY AND COMPANY
  • ERIGAL LIMITED
  • FUJIFILM IR PHARMA CO. LTD.
  • GE HEALTHCARE (SUBSIDIARY OF GENERAL ELECTRIC COMPANY)
  • ISOTEX DIAGNOSTICS INC.
  • IBA MOLECULAR
  • ISORAY MEDICAL
  • JAZZ PHARMACEUTICALS
  • JUBILANT DRAXIMAGE INC.
  • LANTHEUS MEDICAL IMAGING INC.
  • MALLINCKRODT
  • NATIONAL CENTRE FOR NUCLEAR RESEARCH POLATOM
  • NATIONAL INSTITUTE OF RADIOELEMENT (IRE)
  • NAVIDEA BIOPHARMACEUTICALS INC.
  • NORDION INC.
  • NTP RADIOISOTOPES (PTY) LTD.
  • PHARMALUCENSE INC.
  • PIRAMAL IMAGING
  • SIEMENS AG
  • TRIAD ISOTOPES INC.

CHAPTER 11 - ABBREVIATIONS

LIST OF TABLES

  • SUMMARY TABLE: GLOBAL REVENUE OF RADIOPHARMACEUTICALS BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 1: DISCOVERY OF RADIOACTIVITY AND NUCLEAR MEDICINE
    • TABLE 2: CYCLOTRON RADIONUCLIDE/RADIOISOTOPES
    • TABLE 3: NUCLEAR REACTOR RADIONUCLIDES/RADIOISOTOPES
    • TABLE 4: RADIONUCLIDE GENERATORS
    • TABLE 5: EXAMPLES OF DIAGNOSTIC RADIOPHARMACEUTICALS
    • TABLE 6: EXAMPLES OF THERAPEUTIC RADIOPHARMACEUTICALS
    • TABLE 7: EXAMPLES OF ALPHA EMITTERS
    • TABLE 8: ADVANTAGES AND DISADVANTAGES OF ALPHA EMITTERS
    • TABLE 9: ADVANTAGES AND DISADVANTAGES OF BETA EMITTERS
    • TABLE 10: COMMONLY USED RADIONUCLIDES (RADIATION SOURCES) FOR BRACHYTHERAPY
    • TABLE 11: ADVANTAGES AND DISADVANTAGES OF BRACHYTHERAPY
    • TABLE 12: ADVANTAGES AND DISADVANTAGES OF RADIOPHARMACEUTICALS
    • TABLE 13: NEW DRUG APPROVALS (FROM 2011- MARCH 2014)
    • TABLE 14: NEW DRUG APPLICATIONS (FROM 2010-MARCH 2014)
    • TABLE 15: SAFETY ALERTS FOR RADIOPHARMACEUTICALS (FROM 2010-MARCH 2014)
    • TABLE 16: ADVERSE EVENT REPORTING (FROM 2010-MARCH 2014)
    • TABLE 17: RESOLVED DRUG SHORTAGE IN 2013
    • TABLE 18: 510K APPROVALS (FROM 2010-MARCH 2014)
    • TABLE 19: PIPELINE PRODUCTS IN RADIOPHARMACEUTICALS
    • TABLE 20: MARKET FOR RADIOPHARMACEUTICALS BY CATEGORY, THROUGH 2019 ($ MILLIONS)
    • TABLE 21: MARKET SHARE OF RADIOPHARMACEUTICALS BY CATEGORY IN 2013 (%)
    • TABLE 22: MARKET FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE OF DIAGNOSTIC TEST, THROUGH 2019 ($ MILLIONS)
    • TABLE 23: MARKET FOR PET RADIOPHARMACEUTICALS BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 24: MARKET FOR PET RADIOPHARMACEUTICALS BY TYPE OF RADIONUCLIDE, THROUGH 2019 ($ MILLIONS)
    • TABLE 25: MARKET FOR SPECT RADIOPHARMACEUTICALS BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 26: MARKET FOR SPECT RADIOPHARMACEUTICALS BY TYPE OF RADIONUCLIDE, THROUGH 2019 ($ MILLIONS)
    • TABLE 27: MARKET FOR OTHER DIAGNOSTIC RADIOPHARMACEUTICALS BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 28: MARKET FOR OTHERS DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE OF RADIONUCLIDE, THROUGH 2019 ($ MILLIONS)
    • TABLE 29: MARKET SHARE OF DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE OF DIAGNOSTIC TEST IN 2013 (%)
    • TABLE 30: MARKET FOR THERAPEUTIC RADIOPHARMACEUTICALS BY TYPE, THROUGH 2019 ($ MILLIONS)
    • TABLE 31: MARKET FOR ALPHA EMITTERS BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 32: GLOBAL MARKET FOR ALPHA EMITTERS BY TYPE OF RADIONUCLIDE, THROUGH 2019 ($ MILLIONS)
    • TABLE 33: MARKET FOR BETA EMITTERS BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 34: GLOBAL MARKET FOR BETA EMITTERS BY TYPE OF RADIONUCLIDE, THROUGH 2019 ($ MILLIONS)
    • TABLE 35: MARKET FOR BRACHYTHERAPY SEEDS BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 36: MARKET FOR BRACHYTHERAPY BY TYPE OF RADIONUCLIDE, THROUGH 2019 ($ MILLIONS)
    • TABLE 37: MARKET SHARE OF THERAPEUTIC RADIOPHARMACEUTICALS BY TYPE IN 2013 (%)
    • TABLE 38: MARKET FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 39: MARKET SHARE OF DIAGNOSTIC RADIOPHARMACEUTICALS BY REGION IN 2013 (%)
    • TABLE 40: MARKET FOR THERAPEUTIC RADIOPHARMACEUTICALS BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 41: MARKET SHARE OF THERAPEUTIC RADIOPHARMACEUTICALS BY REGION IN 2013 (%)
    • TABLE 42: MARKET FOR RADIOPHARMACEUTICALS BY PRODUCTION METHOD, THROUGH 2019 ($ MILLIONS)
    • TABLE 43: MARKET SHARE OF RADIOPHARMACEUTICALS BY PRODUCTION METHOD, 2013 (%)
    • TABLE 44: GLOBAL MANUFACTURERS/SUPPLIERS OF PET RADIOPHARMACEUTICALS, 2013
    • TABLE 45: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF PET RADIOPHARMACEUTICALS, 2013 (%)
    • TABLE 46: GLOBAL MANUFACTURERS/SUPPLIERS OF SPECT RADIOPHARMACEUTICALS, 2013
    • TABLE 47: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF SPECT RADIOPHARMACEUTICALS, 2013 (%)
    • TABLE 48: GLOBAL MANUFACTURERS/ SUPPLIERS OF OTHER DIAGNOSTIC RADIOPHARMACEUTICALS, 2013
    • TABLE 49: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF OTHER DIAGNOSTIC RADIOPHARMACEUTICALS, 2013 (%)
    • TABLE 50: GLOBAL MANUFACTURERS/SUPPLIERS OF THERAPEUTIC RADIOPHARMACEUTICALS, 2013
    • TABLE 51: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF THERAPEUTIC RADIOPHARMACEUTICALS, 2013 (%)
    • TABLE 52: NUMBER OF SIGNIFICANT PATENTS BY YEAR, JANUARY 2010-APRIL 2014
    • TABLE 53: PATENTS BY CATEGORY, JANUARY 2010-APRIL 2014
    • TABLE 54: NUMBER OF U.S. PATENTS BY COMPANY, JANUARY 2010-APRIL 2014
    • TABLE 55: NUMBER OF U.S. PATENTS BY COUNTRY, JANUARY 2010-APRIL 2014
    • TABLE 56: PATENT SHARES, BY COUNTRY, JANUARY 2010-APRIL 2014 (%)
    • TABLE 57: NUMBER OF PATENTS BY ASSIGNEE, JANUARY 2010-APRIL 2014

LIST OF FIGURES

  • SUMMARY FIGURE: GLOBAL REVENUE OF RADIOPHARMACEUTICALS BY REGION, 2012-2019 ($ MILLIONS)
    • FIGURE 1: MARKET FOR RADIOPHARMACEUTICALS BY CATEGORY, 2012-2019 ($ MILLIONS)
    • FIGURE 2: MARKET SHARE OF RADIOPHARMACEUTICALS BY CATEGORY IN 2013 (%)
    • FIGURE 3: MARKET FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE OF DIAGNOSTIC TEST, 2012-2019 ($ MILLIONS)
    • FIGURE 4: MARKET FOR PET RADIOPHARMACEUTICALS BY REGION, THROUGH 2019 ($ MILLIONS)
    • FIGURE 5: MARKET FOR PET RADIOPHARMACEUTICALS BY TYPE OF RADIONUCLIDE, 2012-2019 ($ MILLIONS)
    • FIGURE 6: MARKET FOR SPECT RADIOPHARMACEUTICALS BY REGION, THROUGH 2019 ($ MILLIONS)
    • FIGURE 7: MARKET FOR SPECT RADIOPHARMACEUTICALS BY TYPE OF RADIONUCLIDE, THROUGH 2019 ($ MILLIONS)
    • FIGURE 8: MARKET FOR OTHER DIAGNOSTIC RADIOPHARMACEUTICALS BY REGION, THROUGH 2019 ($ MILLIONS)
    • FIGURE 9: MARKET FOR OTHERS DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE OF RADIONUCLIDE, THROUGH 2019 ($ MILLIONS)
    • FIGURE 10: MARKET SHARE OF DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE OF DIAGNOSTIC TEST IN 2013 (%)
    • FIGURE 11: MARKET FOR THERAPEUTIC RADIOPHARMACEUTICALS BY TYPE, THROUGH 2019 ($ MILLIONS)
    • FIGURE 12: MARKET FOR ALPHA EMITTERS BY REGION, THROUGH 2019 ($ MILLIONS)
    • FIGURE 13: GLOBAL MARKET FOR ALPHA EMITTERS BY TYPE OF RADIONUCLIDE, THROUGH 2019 ($ MILLIONS)
    • FIGURE 14: MARKET FOR BETA EMITTERS BY REGION, THROUGH 2019 ($ MILLIONS)
    • FIGURE 15: GLOBAL MARKET FOR BETA EMITTERS BY TYPE OF RADIONUCLIDE, THROUGH 2019 ($ MILLIONS)
    • FIGURE 16: MARKET FOR BRACHYTHERAPY SEEDS BY REGION, THROUGH 2019 ($ MILLIONS)
    • FIGURE 17: MARKET FOR BRACHYTHERAPY BY TYPE OF RADIONUCLIDE, THROUGH 2019 ($ MILLIONS)
    • FIGURE 18: MARKET SHARE OF THERAPEUTIC RADIOPHARMACEUTICALS BY TYPE IN 2013 (%)
    • FIGURE 19: MARKET FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY REGION, THROUGH 2019 ($ MILLIONS)
    • FIGURE 20: MARKET SHARE OF DIAGNOSTIC RADIOPHARMACEUTICALS BY REGION IN 2013 (%)
    • FIGURE 21: MARKET FOR THERAPEUTIC RADIOPHARMACEUTICALS BY REGION, THROUGH 2019 ($ MILLIONS)
    • FIGURE 22: MARKET SHARE OF THERAPEUTIC RADIOPHARMACEUTICALS BY REGION IN 2013 (%)
    • FIGURE 23: MARKET FOR RADIOPHARMACEUTICALS BY PRODUCTION METHOD, THROUGH 2019 ($ MILLIONS)
    • FIGURE 24: MARKET SHARE OF RADIOPHARMACEUTICALS BY PRODUCTION METHOD, 2013 (%)
    • FIGURE 25: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF PET RADIOPHARMACEUTICALS, 2013 (%)
    • FIGURE 26: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF SPECT RADIOPHARMACEUTICALS, 2013 (%)
    • FIGURE 27: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF OTHER DIAGNOSTIC RADIOPHARMACEUTICALS, 2013 (%)
    • FIGURE 28: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF THERAPEUTIC RADIOPHARMACEUTICALS, 2013 (%)
    • FIGURE 29: NUMBER OF SIGNIFICANT PATENTS BY YEAR, JANUARY 2010-APRIL 2014
    • FIGURE 30: PATENTS BY CATEGORY, JANUARY 2010-APRIL 2014
    • FIGURE 31: NUMBER OF U.S. PATENTS BY COMPANY, JANUARY 2010-APRIL 2014
    • FIGURE 32: NUMBER OF U.S. PATENTS BY COUNTRY, JANUARY 2010-APRIL 2014
    • FIGURE 33: PATENT SHARES BY COUNTRY, JANUARY 2010-APRIL 2014 (%)
    • FIGURE 34: NUMBER OF PATENTS BY ASSIGNEE, JANUARY 2010-APRIL 2014
Back to Top